Efficacy and Tolerability of Aripiprazole in a Nigerian Cohort with First-episode Psychosis: A Post-marketing Survey

Journal Title: International Neuropsychiatric Disease Journal - Year 2017, Vol 10, Issue 1

Abstract

Background: Individuals with first episode psychoses often discontinue pharmacotherapy due to poor symptom remission and/or intolerable side effects. Aripiprazole has been reported to show good efficacy with low side effect profiles in Caucasians. No studies have been conducted to assess its effectiveness and tolerability in a Nigerian population hence the need for this study. Methods: A post marketing surveillance was conducted involving patients with first episode psychosis presenting to a regional tertiary psychiatric facility in Nigeria. Participants were titrated through a dose range of 10-30 mg of aripiprazole depending on response or tolerability and followed up over a 12 week period. Assessments at baseline, at 2, 6, and 12-weeks post recruitment were done to rate severity of psychopathology (CGI, PANSS), side effects (MSAS), functioning (GAF), and medication adherence (MARS). Results: Of fifty patients completing the study (49.5% drop-out rate), we observed significant improvements at 12 weeks compared to baseline in symptom remission (p<0.001), clinician rating of improvement (p<0.01), and psychosocial functioning (p<0.001). There were no significant changes compared to baseline as regards medication adherence, extra pyramidal side effects (p=0.23), fasting blood sugar (p=0.67) and fasting cholesterol (p=0.57) Conclusion: Aripiprazole may be effective and tolerable among individuals with first episode non-affective psychoses presenting at a tertiary psychiatric facility in Nigeria.

Authors and Affiliations

S. O. Olotu, I. O. Agbonile, J. O. Omoaregba, B. O. James

Keywords

Related Articles

Socio-Demographic and Clinical Features of Children with Intellectual Disability and Their Parents-an Indian Study

Aim: Intellectual disability often referred to as a mental, cognitive or mental retardation is a lifelong condition that affects intellectual functioning and adaptive behaviors. Information about children with intellectu...

Examining the Impact of Patient-Reported Hope for Improvement and Patient Satisfaction with Clinician/Treatment on the Outcome of Major Depressive Disorder Treatment

Aims: This analysis aims at examining if patient-reported variables such as hope for improvement and patient satisfaction with clinician/treatment could influence the outcome major depressive disorder (MDD) treatment, na...

Gender Differences, Personality Traits and Mental Health among Secondary School Adolescents in Enugu, South East Nigeria

Background: Our thinking, feelings and behaviour as well as our unique individuality can contribute a lot to our mental health. Furthermore based on personality traits it has been argued that some people may be more pron...

A Rare Case of Third Ventricular Epidermoid Cyst as Seen by Newer MRI Sequences

Aim: We describe a 52 year old gentleman who had a third ventricular lesion, presumed to be epidermoid cyst, which is very rare. We also describe the appearances of this rare condition on newer MRI sequences. Presentatio...

Diffusion-weighted MR Imaging of the Brain: Correlation of Ischemic Lesion Patterns with ASCO Stroke Subtypes

Background: There are many etiologies for ischemic cerebral stroke. Previous studies have not shown whether specific ischemic lesion patterns on early brain diffusion-weighted imaging (DWI) are associated with specific i...

Download PDF file
  • EP ID EP308482
  • DOI 10.9734/INDJ/2017/34977
  • Views 129
  • Downloads 0

How To Cite

S. O. Olotu, I. O. Agbonile, J. O. Omoaregba, B. O. James (2017). Efficacy and Tolerability of Aripiprazole in a Nigerian Cohort with First-episode Psychosis: A Post-marketing Survey. International Neuropsychiatric Disease Journal, 10(1), 1-10. https://europub.co.uk/articles/-A-308482